Mitchell Mcleod Pugh & Williams Inc. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 8.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 543 shares of the medical equipment provider’s stock after purchasing an additional 40 shares during the period. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Intuitive Surgical were worth $283,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. AE Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 24.5% in the 2nd quarter. AE Wealth Management LLC now owns 3,822 shares of the medical equipment provider’s stock valued at $1,700,000 after acquiring an additional 752 shares during the last quarter. Epoch Investment Partners Inc. lifted its stake in shares of Intuitive Surgical by 7.1% in the 2nd quarter. Epoch Investment Partners Inc. now owns 1,036 shares of the medical equipment provider’s stock valued at $461,000 after purchasing an additional 69 shares during the last quarter. Fidelis Capital Partners LLC boosted its holdings in shares of Intuitive Surgical by 5.3% in the 2nd quarter. Fidelis Capital Partners LLC now owns 2,438 shares of the medical equipment provider’s stock worth $1,095,000 after purchasing an additional 123 shares during the period. EverSource Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 32.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock valued at $514,000 after purchasing an additional 281 shares during the last quarter. Finally, Edge Capital Group LLC raised its holdings in Intuitive Surgical by 6.3% during the 2nd quarter. Edge Capital Group LLC now owns 744 shares of the medical equipment provider’s stock valued at $331,000 after buying an additional 44 shares during the period. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Stock Up 1.5 %
Shares of Intuitive Surgical stock opened at $592.64 on Tuesday. The company has a market cap of $211.09 billion, a P/E ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. The firm’s 50 day moving average price is $540.66 and its 200-day moving average price is $499.64. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $597.68.
Analyst Upgrades and Downgrades
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,509 shares of company stock valued at $22,602,212 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Manufacturing Stocks Investing
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.